Cargando…

Correction: Safety and Efficacy Assessment of Two New Leprosy Skin Test Antigens: Randomized Double Blind Clinical Study

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085061/ http://dx.doi.org/10.1371/journal.pntd.0003065

Ejemplares similares

Safety and Efficacy Assessment of Two New Leprosy Skin Test Antigens: Randomized Double Blind Clinical Study
por: Rivoire, Becky L., et al.
Publicado: (2014)

Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
por: Joharchi, Khojasteh, et al.
Publicado: (2019)

Correction to: Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials
por: Liu, Junhao, et al.
Publicado: (2020)

Correction to “Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study”
por: Gutierrez, Juan E, et al.
Publicado: (2015)

Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
por: Kinoshita, Taku, et al.
Publicado: (2022)

Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
por: Wu, Yan, et al.
Publicado: (2023)

Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy
por: Langlois, Alexandra, et al.
Publicado: (2020)

Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
por: Nahas, Stephanie J., et al.
Publicado: (2022)

Correction: Perceived Stigma towards Leprosy among Community Members Living Close to Nonsomboon Leprosy Colony in Thailand
Publicado: (2015)

Correction: The role of perceptions and knowledge of leprosy in the elimination of leprosy: A baseline study in Fatehpur district, northern India
por: van ‘t Notableordende, Anna T., et al.
Publicado: (2022)

Correction: A Randomized, Double-Blind Trial of Lisinopril and Losartan for the Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy
Publicado: (2015)

Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol
por: Mera-Cordero, Francisco, et al.
Publicado: (2022)

Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
por: Khanna, Sahil, et al.
Publicado: (2022)

Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480]
por: den Hertog, Heleen M, et al.
Publicado: (2008)

Correction: A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
por: Rayamajhi, Ajit, et al.
Publicado: (2015)

Correction: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial
por: Navarro, Victor J., et al.
Publicado: (2019)

Correction: A Randomised, Double-Blind, Controlled Efficacy Trial of the LiESP/QA-21 Vaccine in Naïve Dogs Exposed to Two Leishmania infantum Transmission Seasons
Publicado: (2014)

Correction: Aspartame Sensitivity? A Double Blind Randomised Crossover Study
Publicado: (2015)

Correction to: A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex® in patients with anaemia of chronic renal failure
por: Lim, Soo Kun, et al.
Publicado: (2022)

Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study
por: Motoya, Satoshi, et al.
Publicado: (2019)

Correction to: Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients
Publicado: (2022)

Author Correction: Efficacy and safety assessment of two enterococci phages in an in vitro biofilm wound model
por: Melo, Luís D. R., et al.
Publicado: (2021)

Correction: Effects of Two Chinese Herbal Formulae for the Treatment of Moderate to Severe Stable Chronic Obstructive Pulmonary Disease: A Multicenter, Double-Blind, Randomized Controlled Trial
por: Wang, Genfa, et al.
Publicado: (2016)

Correction: The Burden of Leprosy in Cameroon: Fifteen Years into the Post-elimination Era
por: Tabah, Earnest Njih, et al.
Publicado: (2017)

Correction: Short-term leprosy forecasting from an expert opinion survey
por: Deiner, Michael S., et al.
Publicado: (2017)

Correction to: “Efficacy of surgical skin preparation solutions in hip arthroplasty: a prospective randomized trial”
Publicado: (2022)

Author Correction: Leprosy incidence and risk estimates in a 33-year contact cohort of leprosy patients
por: Hacker, Mariana Andrea, et al.
Publicado: (2021)

The Immunological Skin Tests in Leprosy (Part-III): The Isolated Protein Antigen in Relation to the Antigens used by Other Workers
por: Dharmendra,, et al.
Publicado: (2012)

Safety of a Novel ESAT6-CFP10 skin test compared with tuberculin skin test in a double-blind, randomized, controlled study
por: Yang, Yang, et al.
Publicado: (2022)

Correction: Effect of Broccoli Sprouts on Nasal Response to Live Attenuated Influenza Virus in Smokers: A Randomized, Double-Blind Study
Publicado: (2014)

Correction to: Ginkgo biloba extract EGb 761(®) versus pentoxifylline in chronic tinnitus: a randomized, double-blind clinical trial
por: Procházková, Klára, et al.
Publicado: (2018)

Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
por: Leung, Christopher Kai Shun, et al.
Publicado: (2022)

Correction: Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
por: Schepens, Emma J. A., et al.
Publicado: (2023)

Correction: Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial
por: Tregnaghi, Miguel W., et al.
Publicado: (2015)

Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections
por: Nestler, S., et al.
Publicado: (2023)

Correction: The life experience of leprosy families in maintaining interaction patterns in the family to support healing in leprosy patients in Indonesian society. A phenomenological qualitative study
Publicado: (2022)

Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study
por: Ji, Linong, et al.
Publicado: (2021)

Correction: Leprosy among Patient Contacts: A Multilevel Study of Risk Factors
por: Sales, Anna M., et al.
Publicado: (2011)

The Immunological Skin Tests in Leprosy (Part-I): The Isolation of a Protein Antigen of Mycobacterium Lepræ
por: Dharmendra,
Publicado: (2012)

Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial
por: Wise, Robert A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_luf41h6i8buhduq3nemr4p7sjg